Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Vice President Joe Biden

Stockton University’s Hughes Center to Honor Six on November 9; Former VP Biden to Present Special Honor

Galloway, NJ, October 11, 2017 — The Hughes Center Honors will recognize six outstanding New Jersey leaders at the Stockton Seaview Hotel & Golf Club on Thursday, November 9.

Among those honored will be the late Jim Whelan, who served as a City Councilman and Mayor of Atlantic City and later a state Senator until his death in August.

“We mourn the loss of Sen Whelan, but welcome the opportunity to honor his memory and share his legacy as we recognize the accomplishments of all our honorees,” said Sharon Schulman, executive director of the Hughes Center for Public Policy at Stockton University. Continue reading

VP Joe Biden and Dr. Jill Biden Launch Biden Cancer Initiative; Aims to Make Progress in Cancer Prevention, Detection, Treatment, Care

Dr. Jill Biden and Joe Biden

New York, NY, June 23, 2017 — President Joe Biden and Dr. Jill Biden on June 26 launched the Biden Cancer Initiative, their new venture to continue the fight to make progress in cancer prevention, detection, treatment, and care.

The launch event was highlighted by Vice President and Dr. Biden joining members of the Biden Cancer Initiative Board of Directors for a conversation about the mission of the Initiative, the issues it will address, and the promise of what they hope to accomplish together.

The Biden Cancer Initiative will develop and drive implementation of solutions to accelerate progress in cancer prevention, detection, diagnosis, research and care, and to reduce disparities in cancer outcomes. Continue reading

Former VP Biden to Keynote Stockton University’s 2017 Hughes Center Honors; Six New Jersey Leaders to Be Recognized November 9

Galloway, NJ, July 18, 2017 — Former Vice President Joe Biden will be the keynote speaker when Ambassador William J. Hughes receives the Distinguished Lifetime Achievement Award at the Hughes Center Honors on Nov. 9, 2017.

The Hughes Center Honors are awarded for professional excellence and a commitment to public service, civility and bipartisanship which reflect the life and career of Ambassador Hughes, who served as U.S. ambassador to Panama and as a U.S. congressman for 20 years.

The event, which is open to the public, will start at 5:30 at the Stockton Seaview Hotel & Golf Club. Continue reading

National Cancer Institute and Drug Companies Aim to Speed Up Clinical Trials

nih-national-cancer-instituteBethesda, MD, January 13, 2017 — The National Cancer Institute (NCI) on January 11 launched a new drug formulary (the “NCI Formulary”) that will enable investigators at NCI-designated Cancer Centers to have quicker access to approved and investigational agents for use in preclinical studies and cancer clinical trials.

The NCI Formulary could ultimately translate into speeding the availability of more-effective treatment options to patients with cancer.

The NCI Formulary is a public-private partnership between NCI, part of the National Institutes of Health, and pharmaceutical and biotechnology companies. Continue reading

VP Biden Outlines Steps to Pursue Post-Obama ‘Cancer Moonshot’

Vice President Joe Biden

Vice President Joe Biden

Washington, DC, January 11, 2017 — Vice President Joe Biden is outlining how he intends to pursue his “cancer moonshot” agenda after the end of the Obama administration, the Associated Press reports.

Biden says in a San Francisco speech that he will be starting an organization that may be called the Biden Cancer Initiative to make progress in changing the way the nation conducts cancer research and development and providing care to those with the disease. Continue reading

Vice President Biden to Tackle Broad Range of Cancer Issues After Leaving White House

Vice President Joe Biden

Vice President Joe Biden

Washington, DC, January 6, 2017 — Laurie McGinley reports in The Washington Post that Vice President Joe Biden, who led the Obama administration’s “cancer moonshot” initiative, will create a nonprofit organization to grapple with a broad range of cancer issues.

In an interview on January 4, Biden said, “I’m going to begin a national conversation and get Congress and advocacy groups in to make sure these treatments are accessible for everyone, including these vulnerable underserved populations, and that we have a more rational way of paying for them while promoting innovation.” Continue reading

President Obama Signs 21st Century Cures Legislation; Aims to Accelerate Medical Innovation

President Barack Obama

President Barack Obama

Washington, DC, December 14, 2016 — President Obama signed legislation Tuesday that aims to increase funding for medical research, speed the development and approval of experimental treatments and overhaul federal policy on mental health care, Juliet Eilperin and Carolyn Y. Johnson report in The Washington Post.

“We are bringing to reality the possibility of new breakthroughs to some of the greatest health-care challenges of our time,” President Obama said.

“It is wonderful to see how well Democrats and Republicans in the closing day of this Congress came together around a common cause,” Obama said.  “And I think it indicates the power of this issue and how deeply it touches every family across America.” Continue reading

VP Biden’s Cancer ‘Moonshot’ Project Hangs in Balance as Trump Readies for Presidency

Vice President Joe Biden

Vice President Joe Biden

 Washington, DC, November 26, 2016 — Dylan Scott reports in STAT that Vice President Joe Biden’s cancer “moonshot” is in serious jeopardy following Donald Trump’s election, but there may be hope for it yet.

The president-elect hasn’t said anything about the initiative, launched by the Obama administration earlier this year, and his aides didn’t reply to multiple requests for comment.

But the lame-duck Congress is making a last-ditch effort to pass a medical innovation bill that would provide hundreds of millions of dollars in funding for the effort. Continue reading

STAT: VP Biden Unveils ‘Cancer Moonshot’ Report; Here Are 3 Big Projects the White House Is Pursuing

STATWashington, DC, October 18, 2016 — Dylan Scott reports on STAT that the White House’s cancer moonshot, the future of which Vice President Joe Biden outlined in a new report on October 17, has a lot of moving parts.

The report details nearly 20 projects that are already underway or soon will be in the moonshot’s first year and another two dozen planned for its second year and beyond.

Major themes include harnessing big data, sharing research among scientists, and expanding preventive measures like the HPV vaccine and colorectal cancer screening.  Some of these efforts will be run by the government; others are being led by the private sector.

Here are three big projects that caught our eye. Continue reading

STAT: Scientists Present Sweeping Recommendations for VP Biden’s Cancer ‘Moonshot’ Initiative

Vice President Joe Biden

Vice President Joe Biden

Washington, DC, September 8, 2016 — Dylan Scott reports on STAT that a panel of top scientists on Wednesday urged the Obama administration to bet big on tumor profiling and immunotherapy treatments in its cancer moonshot — two areas that are viewed with great promise, but still face unanswered questions about their ultimate effectiveness.

Scott reports that the experts are recommending the creation of a new national network that would allow cancer patients across the U.S. to have their tumors genetically profiled and included in a new national database — one of several recommended steps that they say would significantly speed the progress of cancer research in the United States.

The panel also is urging the creation of a network to coordinate clinical trials using immunotherapy, the promising new treatment that turns the body’s immune system against the disease. Continue reading